Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Michael John Barry, M.D.

TitleClinical Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Medical Practices Evaluatn Ctr, 9th Fl
50 Staniford Street
Boston MA 02114
Phone617/726-5211
Fax617/726-4120

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Horowitz RE, Provizer H, Barry MJ. How to evaluate a potential merger or acquisition. Arch Pathol Lab Med. 2013 Dec; 137(12):1811-5.
    View in: PubMed
  2. Hoffman RM, Penson DF, Zietman AL, Barry MJ. Comparative effectiveness research in localized prostate cancer treatment. J Comp Eff Res. 2013 Nov; 2(6):583-93.
    View in: PubMed
  3. Hayes JH, Barry MJ, McMahon PM. Observation versus initial treatment for prostate cancer. Ann Intern Med. 2013 Oct 15; 159(8):574.
    View in: PubMed
  4. Barry MJ, Andriole GL, Culkin DJ, Fox SH, Jones KM, Carlyle MH, Wilt TJ. Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial. Clin Trials. 2013; 10(6):907-14.
    View in: PubMed
  5. Fowler FJ, Gerstein BS, Barry MJ. How patient centered are medical decisions?: results of a national survey. JAMA Intern Med. 2013 Jul 8; 173(13):1215-21.
    View in: PubMed
  6. Ledwidge M, Gallagher J, Conlon C, Tallon E, O'Connell E, Dawkins I, Watson C, O'Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA. 2013 Jul 3; 310(1):66-74.
    View in: PubMed
  7. Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Ann Intern Med. 2013 Jun 18; 158(12):853-60.
    View in: PubMed
  8. Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P. Screening for prostate cancer: a guidance statement from the clinical guidelines committee of the american college of physicians. Ann Intern Med. 2013 May 21; 158(10):761-9.
    View in: PubMed
  9. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):419-26.
    View in: PubMed
  10. Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst. 2013 May 15; 105(10):711-8.
    View in: PubMed
  11. Fogarty E, Walsh C, Adams R, McGuigan C, Barry M, Tubridy N. Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D. Mult Scler. 2013 Aug; 19(9):1190-6.
    View in: PubMed
  12. Lee JY, Moore P, Kusek J, Barry M. Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med. 2014 Jan; 20(1):48-52.
    View in: PubMed
  13. Andriole GL, McCullum-Hill C, Sandhu GS, Crawford ED, Barry MJ, Cantor A. The Effect of Increasing Doses of Saw Palmetto Fruit Extract on Serum Prostate Specific Antigen: Analysis of the CAMUS Randomized Trial. J Urol. 2013 Feb; 189(2):486-92.
    View in: PubMed
  14. Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA, Gillick MR, Walker-Corkery ES, Chang Y, López L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED, Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS. Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. J Clin Oncol. 2013 Jan 20; 31(3):380-6.
    View in: PubMed
  15. Atlas SJ, Ashburner JM, Chang Y, Lester WT, Barry MJ, Grant RW. Population-based breast cancer screening in a primary care network. Am J Manag Care. 2012 Dec; 18(12):821-9.
    View in: PubMed
  16. Hoffman RM, Barry MJ, Roberts RG, Sox HC. Reconciling primary care and specialist perspectives on prostate cancer screening. Ann Fam Med. 2012 Nov; 10(6):568-71.
    View in: PubMed
  17. Avins AL, Lee JY, Meyers CM, Barry MJ. Safety and Toxicity of Saw Palmetto in the CAMUS Trial. J Urol. 2013 Apr; 189(4):1415-20.
    View in: PubMed
  18. Barry MJ, Roberts WC. MICHAEL JOHN BARRY, MD: a conversation with the editor on shared decision making. Proc (Bayl Univ Med Cent). 2012 Oct; 25(4):383-8.
    View in: PubMed
  19. Barry MJ, Cantor A, Roehrborn CG. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol. 2013 Mar; 189(3):987-92.
    View in: PubMed
  20. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012 Jul 19; 367(3):203-13.
    View in: PubMed
  21. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct; 27(10):1361-7.
    View in: PubMed
  22. Barry MJ. Shared decision making: informing and involving patients to do the right thing in health care. J Ambul Care Manage. 2012 Apr-Jun; 35(2):90-8.
    View in: PubMed
  23. Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012 Mar 1; 366(9):780-1.
    View in: PubMed
  24. Fowler FJ, Gallagher PM, Bynum JP, Barry MJ, Lucas FL, Skinner JS. Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer. J Gen Intern Med. 2012 Aug; 27(8):911-6.
    View in: PubMed
  25. Barry MJ, Gallagher PM, Skinner JS, Fowler FJ. Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol. 2012 Feb 10; 30(5):513-8.
    View in: PubMed
  26. Grant RW, Ashburner JM, Hong CS, Hong CC, Chang Y, Barry MJ, Atlas SJ. Defining patient complexity from the primary care physician's perspective: a cohort study. Ann Intern Med. 2011 Dec 20; 155(12):797-804.
    View in: PubMed
  27. Volandes AE, Barry MJ, Wood F, Elwyn G. Audio-video decision support for patients: the documentary genré as a basis for decision aids. Health Expect. 2013 Sep; 16(3):e80-8.
    View in: PubMed
  28. McNaughton-Collins MF, Barry MJ. One man at a time--resolving the PSA controversy. N Engl J Med. 2011 Nov 24; 365(21):1951-3.
    View in: PubMed
  29. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011; (10):CD001431.
    View in: PubMed
  30. Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011 Sep 28; 306(12):1344-51.
    View in: PubMed
  31. Barry MJ. Helping patients make better personal health decisions: the promise of patient-centered outcomes research. JAMA. 2011 Sep 21; 306(11):1258-9.
    View in: PubMed
  32. Adams R, Craig BM, Walsh CD, Veale DJ, Bresnihan B, FitzGerald O, Barry M. The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohort. Value Health. 2011 Sep-Oct; 14(6):921-7.
    View in: PubMed
  33. Barry MJ, Avins AL, Meleth S. Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item. Urology. 2011 Sep; 78(3):550-4.
    View in: PubMed
  34. Wharam JF, Frank MB, Rosland AM, Paasche-Orlow MK, Farber NJ, Sinsky C, Rucker L, Rask KJ, Barry MJ, Figaro MK. "Pay-for-performance" as a quality improvement tool: perceptions and policy recommendations of physicians and program leaders. Qual Manag Health Care. 2011 Jul-Sep; 20(3):234-45.
    View in: PubMed
  35. Hayes J, Barry MJ. Preventing prostate cancer overdiagnosis from becoming overtreatment. Oncology (Williston Park). 2011 May; 25(6):468, 471, 478.
    View in: PubMed
  36. Barry M. Documenting the genie's escape: robotic surgery. Med Care. 2011 Apr; 49(4):340-2.
    View in: PubMed
  37. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011 May; 185(5):1793-803.
    View in: PubMed
  38. Barry M, Levin C, MacCuaig M, Mulley A, Sepucha K. Shared decision making: vision to reality. Health Expect. 2011 Mar; 14 Suppl 1:1-5.
    View in: PubMed
  39. Barry MJ. Good night, Irene. Ann Intern Med. 2011 Feb 1; 154(3):209-10.
    View in: PubMed
  40. Hoffman RM, Roberts RG, Barry MJ. Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory? J Gen Intern Med. 2011 Jul; 26(7):798-801.
    View in: PubMed
  41. Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010 Dec 1; 304(21):2373-80.
    View in: PubMed
  42. LaRocque RC, Rao SR, Tsibris A, Lawton T, Barry MA, Marano N, Brunette G, Yanni E, Ryan ET. Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med. 2010 Nov-Dec; 17(6):387-91.
    View in: PubMed
  43. Atlas SJ, Grant RW, Lester WT, Ashburner JM, Chang Y, Barry MJ, Chueh HC. A cluster-randomized trial of a primary care informatics-based system for breast cancer screening. J Gen Intern Med. 2011 Feb; 26(2):154-61.
    View in: PubMed
  44. Hong CS, Atlas SJ, Chang Y, Subramanian SV, Ashburner JM, Barry MJ, Grant RW. Relationship between patient panel characteristics and primary care physician clinical performance rankings. JAMA. 2010 Sep 8; 304(10):1107-13.
    View in: PubMed
  45. Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, Levin CA, Van Hoewyk J, Zikmund-Fisher BJ. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010 Sep-Oct; 30(5 Suppl):53S-64S.
    View in: PubMed
  46. Barry MA. A 29-year-old woman with flu-like symptoms: review of influenza diagnosis and treatment. JAMA. 2010 Aug 11; 304(6):671-8.
    View in: PubMed
  47. Lee CN, Dominik R, Levin CA, Barry MJ, Cosenza C, O'Connor AM, Mulley AG, Sepucha KR. Development of instruments to measure the quality of breast cancer treatment decisions. Health Expect. 2010 Sep; 13(3):258-72.
    View in: PubMed
  48. Barry MJ. The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer". Arch Intern Med. 2010 Mar 8; 170(5):450-2.
    View in: PubMed
  49. Barry MJ, Schroeder AA. Cavernous sinus syndrome secondary to pituitary adenoma: A case report. Ear Nose Throat J. 2010 Feb; 89(2):E1-3.
    View in: PubMed
  50. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62.
    View in: PubMed
  51. Barry M. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Dec 31; 361(27):2674; author reply 2675.
    View in: PubMed
  52. Sepucha KR, Barry MJ. Making patient-centered cancer care a reality. Cancer. 2009 Dec 15; 115(24):5610-1.
    View in: PubMed
  53. Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials. 2009 Dec; 6(6):628-36.
    View in: PubMed
  54. El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE. Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial. J Clin Oncol. 2010 Jan 10; 28(2):305-10.
    View in: PubMed
  55. Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC, Keating NL. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA. 2009 Oct 14; 302(14):1557-64.
    View in: PubMed
  56. Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med. 2009 Sep 28; 169(17):1611-8.
    View in: PubMed
  57. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA. 2009 Sep 16; 302(11):1202-9.
    View in: PubMed
  58. Volandes AE, Barry MJ, Chang Y, Paasche-Orlow MK. Improving decision making at the end of life with video images. Med Decis Making. 2010 Jan-Feb; 30(1):29-34.
    View in: PubMed
  59. Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS. A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy. J Urol. 2009 Sep; 182(3):956-65.
    View in: PubMed
  60. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; (3):CD001431.
    View in: PubMed
  61. Volandes AE, Paasche-Orlow MK, Barry MJ, Gillick MR, Minaker KL, Chang Y, Cook EF, Abbo ED, El-Jawahri A, Mitchell SL. Video decision support tool for advance care planning in dementia: randomised controlled trial. BMJ. 2009; 338:b2159.
    View in: PubMed
  62. Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP, Mollon P, McKinlay JB. Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology. 2009 May; 73(5):950-7.
    View in: PubMed
  63. Kilbridge KL, Fraser G, Krahn M, Nelson EM, Conaway M, Bashore R, Wolf A, Barry MJ, Gong DA, Nease RF, Connors AF. Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol. 2009 Apr 20; 27(12):2015-21.
    View in: PubMed
  64. Barry MJ. Screening for prostate cancer--the controversy that refuses to die. N Engl J Med. 2009 Mar 26; 360(13):1351-4.
    View in: PubMed
  65. Wharam JF, Paasche-Orlow MK, Farber NJ, Sinsky C, Rucker L, Rask KJ, Figaro MK, Braddock C, Barry MJ, Sulmasy DP. High quality care and ethical pay-for-performance: a Society of General Internal Medicine policy analysis. J Gen Intern Med. 2009 Jul; 24(7):854-9.
    View in: PubMed
  66. Barry MJ, Mulley AJ. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? J Natl Cancer Inst. 2009 Mar 18; 101(6):362-3.
    View in: PubMed
  67. Atlas SJ, Grant RW, Ferris TG, Chang Y, Barry MJ. Patient-physician connectedness and quality of primary care. Ann Intern Med. 2009 Mar 3; 150(5):325-35.
    View in: PubMed
  68. Lester WT, Ashburner JM, Grant RW, Chueh HC, Barry MJ, Atlas SJ. Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network. J Am Med Inform Assoc. 2009 Mar-Apr; 16(2):187-95.
    View in: PubMed
  69. Barry MJ. Screening for prostate cancer among men 75 years of age or older. N Engl J Med. 2008 Dec 11; 359(24):2515-6.
    View in: PubMed
  70. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery E, Barry MJ. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up. J Gen Intern Med. 2008 Nov; 23(11):1809-14.
    View in: PubMed
  71. Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials. 2009 Jan; 30(1):81-7.
    View in: PubMed
  72. Sepucha KR, Levin CA, Uzogara EE, Barry MJ, O'Connor AM, Mulley AG. Developing instruments to measure the quality of decisions: early results for a set of symptom-driven decisions. Patient Educ Couns. 2008 Dec; 73(3):504-10.
    View in: PubMed
  73. Bennett K, Kabir Z, Barry M, Tilson L, Fidan D, Shelley E, Capewell S. Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010. Value Health. 2009 Jan-Feb; 12(1):10-5.
    View in: PubMed
  74. Barry MJ, Kaufman DS, Wu CL. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer. N Engl J Med. 2008 May 15; 358(20):2161-8.
    View in: PubMed
  75. Barry MJ. Commentary: how serious is getting a diagnosis of prostate cancer? Oncologist. 2008 Mar; 13(3):306-8.
    View in: PubMed
  76. Barry MJ, Wescott PH, Reifler EJ, Chang Y, Moulton BW. Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test. J Law Med Ethics. 2008; 36(2):396-402, 214.
    View in: PubMed
  77. Krane M, Barry M, Wei T. Unsteady behavior of flow in a scaled-up vocal folds model. J Acoust Soc Am. 2007 Dec; 122(6):3659-70.
    View in: PubMed
  78. Barry MJ. Editorial comment on: poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. Eur Urol. 2008 Jul; 54(1):116-7.
    View in: PubMed
  79. O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making. 2007 Sep-Oct; 27(5):554-74.
    View in: PubMed
  80. Barnato AE, Llewellyn-Thomas HA, Peters EM, Siminoff L, Collins ED, Barry MJ. Communication and decision making in cancer care: setting research priorities for decision support/patients' decision aids. Med Decis Making. 2007 Sep-Oct; 27(5):626-34.
    View in: PubMed
  81. Barry MJ, Link CL, McNaughton-Collins MF, McKinlay JB. Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women. BJU Int. 2008 Jan; 101(1):45-51.
    View in: PubMed
  82. Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst. 2007 Sep 19; 99(18):1395-400.
    View in: PubMed
  83. Hayes JH, Barry MJ, Kantoff PW, Stahl JE. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective. BJU Int. 2007 Sep; 100(3):486-8.
    View in: PubMed
  84. Hu JC, Link CL, McNaughton-Collins M, Barry MJ, McKinlay JB. The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey. J Gen Intern Med. 2007 Nov; 22(11):1532-7.
    View in: PubMed
  85. Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Aug; 5(7):714-36.
    View in: PubMed
  86. Barry MJ. Words of wisdom: re: survival associated with treatment vs observation of localized prostate cancer in elderly men. Wong Y, Mitra N, Hudes G, et al. JAMA 2006;296:2683-93. Eur Urol. 2007 Jun; 51(6):1751.
    View in: PubMed
  87. Daniels NA, Link CL, Barry MJ, McKinlay JB. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome. J Natl Med Assoc. 2007 May; 99(5):509-16.
    View in: PubMed
  88. Lu-Yao GL, Barry MJ, Albertsen PC, Yao SL. Outcomes of treatment vs observation of localized prostate cancer in elderly men. JAMA. 2007 Apr 18; 297(15):1651; author reply 1652-3.
    View in: PubMed
  89. Patel S, Parsyan AE, Gunn J, Barry MA, Reed C, Sharnprapai S, Horsburgh CR. Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis. Chest. 2007 Jun; 131(6):1811-6.
    View in: PubMed
  90. Barry MJ. Review: evidence from 2 low quality screening studies does not show a reduction in death from prostate cancer. Evid Based Med. 2007 Apr; 12(2):40.
    View in: PubMed
  91. D'Amico AV, Barry MJ. Prostate cancer prevention and finasteride. J Urol. 2006 Nov; 176(5):2010-2; discussion 2012-3.
    View in: PubMed
  92. Atlas SJ, Chang Y, Lasko TA, Chueh HC, Grant RW, Barry MJ. Is this "my" patient? Development and validation of a predictive model to link patients to primary care providers. J Gen Intern Med. 2006 Sep; 21(9):973-8.
    View in: PubMed
  93. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006 Aug 26; 333(7565):417.
    View in: PubMed
  94. Barry MJ, Delorenzo MA, Walker-Corkery ES, Lucas FL, Wennberg DC. The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study. BJU Int. 2006 Nov; 98(5):973-8.
    View in: PubMed
  95. Fowler FJ, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M. The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med. 2006 Jul; 21(7):715-21.
    View in: PubMed
  96. Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med. 2006 May; 119(5):418-25.
    View in: PubMed
  97. Chan EC, Barry MJ, Vernon SW, Ahn C. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey. J Gen Intern Med. 2006 Mar; 21(3):257-9.
    View in: PubMed
  98. Barry MJ. The PSA Conundrum. Arch Intern Med. 2006 Jan 9; 166(1):7-8.
    View in: PubMed
  99. Barry MJ. Editorial: The PSA Conundrum. Arch Int Med. 2006; 166:7-8.
  100. Nelson EM, Fraser G, Connors AF, Barry MJ Krahn M, Conaway MR, Bashore R, Wolf A, Killbridge KL. Misunderstanding of prostate cancer (CaP) among Afracan American (AA) men of lower economic status (Lo-SES). J Clin Oncol. 2006; in press.
  101. Hu JC, Barry MJ, Link CL, McNaughton-Collins MC, McKinlay J. The association of previous sexual, physical, and emotional abuse and chronic prostatis (chronic pelvic pain syndrome) (cp/cps) Results from the Boston Area Community Health (BACH) study. J Urol. 2006; 175(Suppl):7.
  102. McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med. 2005 Dec; 118(12):1331-9.
    View in: PubMed
  103. Barry MJ. Revisiting my personal decision about prostate-specific antigen testing in 2005. BJU Int. 2005 Nov; 96(7):954-6.
    View in: PubMed
  104. Lasko TA, Atlas SJ, Barry MJ, Chueh HC. Automated identification of a physician's primary patients. J Am Med Inform Assoc. 2006 Jan-Feb; 13(1):74-9.
    View in: PubMed
  105. Atlas SJ, McDermott SM, Mannone C, Barry MJ. The role of point of care testing for patients with acute pharyngitis. J Gen Intern Med. 2005 Aug; 20(8):759-61.
    View in: PubMed
  106. Barry MJ. Mortality rate from early prostate cancer increased 3 fold after 15 years following the diagnosis. ACP J Club. 2005 Jan-Feb; 142(1):24.
    View in: PubMed
  107. Barry MJ, Dancey JE. Instruments to measure the specific health impact of surgery, radiation, and chemotherapy on cancer patients. In: Lipscomb J, Gotay CC, Snyder C, eds. Outcomes Assessment in Cancer. 2005; 201-215.
  108. Holmes CB, Singer DE, Barry MJ, McDermott SM, Atlas SJ. . Spectrum of influenza disease at a large medical center during a year of vaccine mismatch. J Gen Intern Med. 2005; 20(Suppl 2):89.
  109. Barry MJ. Commentary: Mortality rate from early prostate cancer 3-fold after 15 years following the diagnosis. ACP Journal Club. 2005; 142:24.
  110. Holmes CB, Singer DE, Barry MJ, McDermott SM, Atlas SJ. Effectiveness of influenza vaccination in a year of poor match between vaccine and circulating strains of influenza: A case-control study. J Gen Intern Med. 2005; 20(Suppl 1):85.
  111. McNaughton-Collins M, Barry MJ, Caubet JF, Bates DW, Lee JM, Hauser A, Fowler FJ. Validity of primary care patient self-report of abnormal (but not cancer) prostate biopsy results. J Urol. 2004 Dec; 172(6 Pt 1):2366-8.
    View in: PubMed
  112. McNaughton-Collins M, Fowler FJ, Caubet JF, Bates DW, Lee JM, Hauser A, Barry MJ. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004 Nov 15; 117(10):719-25.
    View in: PubMed
  113. Barry MJ, Davies W. Effects of invertebrate predators and a pesticide on temporary pond microcosms used for aquatic toxicity testing. Environ Pollut. 2004 Sep; 131(1):25-34.
    View in: PubMed
  114. Elstein AS, Fryback DG, Weinstein MC, Pauker SG, Holmes-Rovner M, Young MJ, Barry MJ, Eckman MH, Hunink MG, Tsevat J, Wong JB. Presidential reflections on the 25th anniversary of the society for medical decision making. Med Decis Making. 2004 Jul-Aug; 24(4):408-20.
    View in: PubMed
  115. Barry M. Rosuvastatin-warfarin drug interaction. Lancet. 2004 Jan 24; 363(9405):328.
    View in: PubMed
  116. Barry MJ. Measuring and assessing BPH in population groups. Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. 2004; 141-150.
  117. Woods R, McCarthy T, Barry MA, Mahon B. Diagnosing smallpox: would you know it if you saw it? Biosecur Bioterror. 2004; 2(3):157-63.
    View in: PubMed
  118. Barnett GO, Barry MJ, Robb-Nicholson C, Morgan M. Overcoming information overload: an information system for the primary care physician. Stud Health Technol Inform. 2004; 107(Pt 1):273-6.
    View in: PubMed
  119. McNaughton-Collins M, Walker-Corkery E, Barry MJ. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. J Natl Cancer Inst Monogr. 2004; (33):78-101.
    View in: PubMed
  120. Ledwidge M, Barry M, Cahill J, Ryan E, Maurer B, Ryder M, Travers B, Timmons L, McDonald K. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail. 2003 Jun; 5(3):381-9.
    View in: PubMed
  121. Hylek EM, Regan S, Henault LE, Gardner M, Chan AT, Singer DE, Barry MJ. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis. Arch Intern Med. 2003 Mar 10; 163(5):621-7.
    View in: PubMed
  122. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003 Mar; 169(3):1065-9; discussion 1069.
    View in: PubMed
  123. Meigs JB, Cagliero E, Dubey A, Murphy-Sheehy P, Gildesgame C, Chueh H, Barry MJ, Singer DE, Nathan DM. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care. 2003 Mar; 26(3):750-7.
    View in: PubMed
  124. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions (Cochrane Review). 2003.
  125. Barry MJ, McNaughton Collins M. Benign Prostatic Hyperplasia and Prostatitis. In: Goldman L, Ausiello D, eds. Cecil Textbook of Medicine. 2003; 775-780.
  126. Barry M, Roehrborn C, Webber R. Benign prostatic hyperplasia. Clin Evid. 2002 Dec; (8):849-63.
    View in: PubMed
  127. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002 Oct 5; 325(7367):740.
    View in: PubMed
  128. McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology. 2002 Oct; 60(4):628-33.
    View in: PubMed
  129. Barry M. Review: Pygeum africanum extracts improve symptoms and urodynamics in symptomatic benign prostatic hyperplasia. ACP J Club. 2002 Sep-Oct; 137(2):61.
    View in: PubMed
  130. Barrt MJ. Benign Prostatic Hyperplasia. 10 Nephrology. ACP Medicine Online. Dale DC, Federman DD, eds. 2002.
  131. Fowler FJ, McNaughton Collins M, Walker Corkery E, Elliott DB, Barry MJ. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer. 2002 Jul 15; 95(2):287-95.
    View in: PubMed
  132. Barry M, Roehrborn C. Benign prostatic hyperplasia. Clin Evid. 2002 Jun; (7):775-87.
    View in: PubMed
  133. Wasson JH, Bubolz TA, Yao GL, Barry MJ. Prostate biopsies in men with limited life expectancy. Eff Clin Pract. 2002 May-Jun; 5(3):137-42.
    View in: PubMed
  134. Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002 Mar; 167(3):1363-6.
    View in: PubMed
  135. Barry MJ. NSAIDs and a lower risk of prostate cancer: causation or confounding? Mayo Clin Proc. 2002 Mar; 77(3):217-8.
    View in: PubMed
  136. Barry MJ. Progress toward understanding the neurophysiological basis of predator-induced morphology in Daphnia pulex. Physiol Biochem Zool. 2002 Mar-Apr; 75(2):179-86.
    View in: PubMed
  137. Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002 Feb; 59(2):245-50.
    View in: PubMed
  138. Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002 Jan 15; 136(2):127-35.
    View in: PubMed
  139. Barry MJ. Fecal occult blood testing for colorectal cancer: a perspective. Ann Oncol. 2002 Jan; 13(1):61-4.
    View in: PubMed
  140. Barry M, Roehrborn C. Benign Prostatic Hyperplasia. In: Barton S, ed. Clinical Evidence. 2002; 649-659.
  141. Bubolz T, Wasson JH, Lu-Yao G, Barry MJ. Treatments for prostate cancer in older men: 1984-1997. Urology. 2001 Dec; 58(6):977-82.
    View in: PubMed
  142. Hammond CS, Wasson JH, Walker-Corkery E, Fowler FJ, Barry MJ. A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. Urology. 2001 Dec; 58(6):875-81.
    View in: PubMed
  143. Barry MJ. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology. 2001 Dec; 58(6 Suppl 1):25-32; discussion 32.
    View in: PubMed
  144. Barry MJ, Roehrborn CG. Benign prostatic hyperplasia. BMJ. 2001 Nov 3; 323(7320):1042-6.
    View in: PubMed
  145. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001 Sep; 54(9):935-44.
    View in: PubMed
  146. Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001 Jun 15; 91(12):2302-14.
    View in: PubMed
  147. Barry MJ. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med. 2001 May 3; 344(18):1373-7.
    View in: PubMed
  148. Taylor KD, Plevy SE, Yang H, Landers CJ, Barry MJ, Rotter JI, Targan SR. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology. 2001 May; 120(6):1347-55.
    View in: PubMed
  149. O"Connor AM, Stacey D, Rovner D, Holmes-Rovner M, Tetroe J, Llewellyn-Thomas H, Entwistle V, Rosstom A, Fiset V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions. (Cochran Review). 2001.
  150. Barry M, Roehrborn C. Benign Prostatic Hyperplasia. In: Barton S, ed. Clinical Evidence. 2001; 588-598.
  151. Barry MJ. Editorial: The impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology. 2001; 57:1085-6.
  152. Barry MJ, Williford WO, Fowler FJ, Jones KM, Lepor H. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia. J Urol. 2000 Nov; 164(5):1559-64.
    View in: PubMed
  153. Barry MJ. Early detection and aggressive treatment of prostate cancer: groping in the dark. J Gen Intern Med. 2000 Oct; 15(10):749-51.
    View in: PubMed
  154. Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol. 2000 Oct; 164(4):1212-5.
    View in: PubMed
  155. Fowler FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000 Jun 28; 283(24):3217-22.
    View in: PubMed
  156. McNaughton Collins M, Fowler FJ, Elliott DB, Albertsen PC, Barry MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology. 2000 Mar; 55(3):403-7.
    View in: PubMed
  157. McNaughton Collins M, Stafford RS, Barry MJ. Age-specific patterns of prostate-specific antigen testing among primary care physician visits. J Fam Pract. 2000 Feb; 49(2):169-72.
    View in: PubMed
  158. Barry MJ, Goodson JD. Screening for prostate cancer. In: Goroll AH, May L, Mulley AG, eds. Primary CAre Medicine. 2000; 743-47.
  159. Barry MJ. Screening for colorectal cancer. In: Goroll AH, May L, Mulley AG, eds. Primary Care Medicine. 2000; 359-363.
  160. Barry MJ, Roehrborn CG. Benign Prostatic Hyperplasia. In: Godlee F, Ed. Clinical Evidence. 2000; 381-88.
  161. Barry MJ, O'Leary MP. Health-related quality of life in men with benign prostatic hyperplasia. In: Narayan P, ed. Benigh Prostatic Hyperplasia. 2000; 69-77.
  162. Barry MJ. Commentary: Antiandrogen treatment immediately after surgery for prostate cancer improved survival. Evidence-Based Medicine. 2000; 5:105.
  163. Barry MJ. The natural history of benign prostatic hyperplasia. In: Lepor H, ed. Prostatic Diseases. 2000; 106-115.
  164. Barry MJ, Goodson JD. Management of benign prostatic hyperplasia. In: Goroll AH, May LA, Mulley AG, eds. Primary Care Medicine. 2000; 794-98.
  165. Barry MJ, Roehrborn CG. Medical management of benign prostatic obstruction. In: Kursh ED, Ulchaker JC, eds. Office Urology: The Clinician's Guide. 2000; 225-235.
  166. Barry MJ. Commentary: Antiandrogen therapy immediately after surgery for prostate cancer improved survival. ACP Journal Club. 2000; 133:29.
  167. Barry M, Roehrborn C. Benign Prostatic Hyperplasia. In: Barton S, ed. Clinical Evidence. 2000; 453-461.
  168. Barry MJ. Involving patients in medical decisions: how can physicians do better? JAMA. 1999 Dec 22-29; 282(24):2356-7.
    View in: PubMed
  169. Barry MJ. Quality of life and prostate cancer treatment. J Urol. 1999 Aug; 162(2):407.
    View in: PubMed
  170. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol. 1999 Aug; 162(2):376-82.
    View in: PubMed
  171. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol. 1999 Jun; 41(6):404-11.
    View in: PubMed
  172. Collins MM, Stafford RS, O'Leary MP, Barry MJ. Distinguishing chronic prostatitis and benign prostatic hyperplasia symptoms: results of a national survey of physician visits. Urology. 1999 May; 53(5):921-5.
    View in: PubMed
  173. Barry MJ, Roehrborn CG. Benign Prostatic Hyperplasia. In: Godlee F, Ed. Clinical Evidence. 1999; 303-10.
  174. Barry MJ. Commentary: Saw palmetto plant extract (Seranoa repens) is effective and safe in benign prostatic hyperplasia. ACP Journal Club. 1999; 130:61.
  175. Barry MJ, et al. Primary Care Operations Improvement Web Site. Commissioned by MGH Primary Care Operations Improvement Committee. Disseminates clinical information and guidelines to MGH primary care physicians. 1999.
  176. Barry MJ. Nonpalpable prostate cancer screening. In: Black ER, Bordley DR, Tape TG, Panzer RJ, eds. Diagnostic Strategies for Common Medical Problems. 1999; 540-48.
  177. Barry M, O'Leary M. Section Editors. Urological Disorders. Clinical Evidence Godlee F, (ed). 1999.
  178. Barry M, Roehrborn C. Benign prostatic hyperplasia. In: Godlee F, ed. Clinical Evidence. 1999; 334-3340.
  179. Barry MJ. Editorial: "Impact of a shared decision-making program on patients with benign prostatic hyperplasia". Urology. 1999; 53:920.
  180. McNaughton Collins M, Barry MJ. The epidemiology of prostatitis. In: Nickel JC, ed. Textbook of Prostatitis. 1999; 247-254.
  181. Barry MJ. PSA screening for prostate cancer: the current controversy--a viewpoint. Patient Outcomes Research Team for Prostatic Diseases. Ann Oncol. 1998 Dec; 9(12):1279-82.
    View in: PubMed
  182. Lepor H, Williford WO, Barry MJ, Haakenson C, Jones K. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. J Urol. 1998 Oct; 160(4):1358-67.
    View in: PubMed
  183. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998 Sep 16; 280(11):975-80.
    View in: PubMed
  184. Collins MM, O'Leary MP, Barry MJ. Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits. Urology. 1998 Sep; 52(3):422-7.
    View in: PubMed
  185. Mulley AG, Barry MJ. Controversy in managing patients with prostate cancer. Banish dogma, get more data. BMJ. 1998 Jun 27; 316(7149):1919-20.
    View in: PubMed
  186. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med. 1998 Jun; 104(6):517-25.
    View in: PubMed
  187. Wasson JH, Fowler FJ, Barry MJ. Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices. J Urol. 1998 Jun; 159(6):1993-6; discussion 1996-7.
    View in: PubMed
  188. Fowler FJ, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998 Jun; 104(6):526-32.
    View in: PubMed
  189. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998 Apr; 159(4):1224-8.
    View in: PubMed
  190. Welch G, Kawachi I, Barry MJ, Giovannucci E, Colditz GA, Willett WC. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study. Urology. 1998 Mar; 51(3):422-7.
    View in: PubMed
  191. Barry MJ. Commentary: Sidenafil improved sexual function in erictile dysfunction. ACP Journal Club. 1998; 129:70.
  192. Barry MJ. Commentary: Finasteride reduced symptoms and need for surgery in benign prostatic hyperplasia. ACP Journal Club. 1998; 129((1)):11.
  193. Barry MJ. Commentary: Sildenafil improved sexual function in erictile dysfunction. Evidence-Based Medicine. 1998; 6:184.
  194. Barry MJ. A 73-year-old man with symptomatic benign prostatic hyperplasia. JAMA. 1997 Dec 24-31; 278(24):2178-84.
    View in: PubMed
  195. McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA. 1997 Nov 12; 278(18):1516-9.
    View in: PubMed
  196. Quirk DM, Barry MJ, Aserkoff B, Podolsky DK. Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology. 1997 Nov; 113(5):1443-8.
    View in: PubMed
  197. Barry MJ. Is there an easier way to determine whether early detection of prostate cancer reduces mortality? J Gen Intern Med. 1997 Oct; 12(10):657-8.
    View in: PubMed
  198. Barry MJ, Fowler FJ, Bin L, Oesterling JE. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer. J Urol. 1997 Aug; 158(2):488-91; discussion 492.
    View in: PubMed
  199. Quirk DM, Barry MJ. Physician specialty and cost-effectiveness of diverticulitis care: a difficult knot to untangle. Gastroenterology. 1997 Jun; 112(6):2147-50.
    View in: PubMed
  200. Collins MM, Barry MJ, Bin L, Roberts RG, Oesterling JE, Fowler FJ. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. J Gen Intern Med. 1997 Apr; 12(4):224-9.
    View in: PubMed
  201. Barry MJ, Roberts RG. Indications for PSA testing. JAMA. 1997 Mar 26; 277(12):955-6.
    View in: PubMed
  202. Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med. 1997 Mar 15; 126(6):468-79.
    View in: PubMed
  203. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med. 1997 Mar 1; 126(5):394-406.
    View in: PubMed
  204. Barry MJ. Lower urinary tract symptoms smorgasbord: international fare. J Urol. 1997 Mar; 157(3):900-1.
    View in: PubMed
  205. Gomelsky A, Barry MJ, Wagner RB. Spontaneous mediastinal hemorrhage: a case report with a review of the literature. Md Med J. 1997 Feb; 46(2):83-7.
    View in: PubMed
  206. Collins MM, Fowler FJ, Roberts RG, Oesterling JE, Annas GJ, Barry MJ. Medical malpractice implications of PSA testing for early detection of prostate cancer. J Law Med Ethics. 1997; 25(4):234-42, 230.
    View in: PubMed
  207. Barry MJ, Fowler FJ, Bin L, Pitts JC, Harris CJ, Mulley AG. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 1997 Jan; 157(1):10-4; discussion 14-5.
    View in: PubMed
  208. Barry MJ, Roehrborn CG. Benign prostatic hyperplasia. In: Dornbrand L, et al. eds. Manual of Clinical Problems in Adult Ambulatory Care. 1997; 631-8.
  209. Barry MJ, O'Leary MP. Commentary: Transurethral alprostadil restored potency in impotent men. ACP Journal Club. 1997; 127((1)):7.
  210. Collins MM, Barry MJ. Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. JAMA. 1996 Dec 25; 276(24):1976-9.
    View in: PubMed
  211. Kawachi I, Barry MJ, Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. The impact of different therapies on symptoms of benign prostatic hyperplasia: a prospective study. Clin Ther. 1996 Nov-Dec; 18(6):1118-27.
    View in: PubMed
  212. Meigs JB, Barry MJ, Oesterling JE, Jacobsen SJ. Interpreting results of prostate-specific antigen testing for early detection of prostate cancer. J Gen Intern Med. 1996 Sep; 11(9):505-12.
    View in: PubMed
  213. Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med. 1996 Aug 22; 335(8):533-9.
    View in: PubMed
  214. Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996 Aug; 14(8):2258-65.
    View in: PubMed
  215. Barry MJ. Prostate disease potpourri--measurement reliability, therapeutic effectiveness and pathophysiological diagnosis. J Urol. 1996 Apr; 155(4):1309-10.
    View in: PubMed
  216. Lu-Yao GL, Potosky AL, Albertsen PC, Wasson JH, Barry MJ, Wennberg JE. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst. 1996 Feb 21; 88(3-4):166-73.
    View in: PubMed
  217. Barry MJ, Walker-Corkery E, Chang Y, Tyll LT, Cherkin DC, Fowler FJ. Measurement of overall and disease-specific health status: does the order of questionnaires make a difference? J Health Serv Res Policy. 1996 Jan; 1(1):20-7.
    View in: PubMed
  218. O'Leary MP, Barry MJ. Evaluating symptoms and functional status. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P, eds. Testbook of Benign Prostatic Hyperplasia. 1996; 140-47.
  219. Miega JB, Barry MJ. The nautral history of benign prostatic hyperplasia. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P, eds. Testbook of Benign Prostatic Hyperplasia. 1996; 125-135.
  220. Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, Lepor H. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol. 1995 Nov; 154(5):1770-4.
    View in: PubMed
  221. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ. A brief male sexual function inventory for urology. Urology. 1995 Nov; 46(5):697-706.
    View in: PubMed
  222. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program. Urology. 1995 Oct; 46(4):445-61.
    View in: PubMed
  223. Barry MJ, Fowler FJ, Chang Y, Liss CL, Wilson H, Stek M. The American Urological Association symptom index: does mode of administration affect its psychometric properties? J Urol. 1995 Sep; 154(3):1056-9.
    View in: PubMed
  224. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes. Urology. 1995 Sep; 46(3):277-89.
    View in: PubMed
  225. Coley CM, Barry MJ, Fleming C, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies. Urology. 1995 Aug; 46(2):125-41.
    View in: PubMed
  226. Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995 Aug; 33(8):771-82.
    View in: PubMed
  227. Wagner EH, Barrett P, Barry MJ, Barlow W, Fowler FJ. The effect of a shared decisionmaking program on rates of surgery for benign prostatic hyperplasia. Pilot results. Med Care. 1995 Aug; 33(8):765-70.
    View in: PubMed
  228. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate. Urology. 1995 Jul; 46(1):2-13.
    View in: PubMed
  229. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995 Jun; 45(6):1007-13; discussion 1013-5.
    View in: PubMed
  230. Barry MJ, O'Leary MP. Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores. Urol Clin North Am. 1995 May; 22(2):299-307.
    View in: PubMed
  231. Aseltine RH, Carlson KJ, Fowler FJ, Barry MJ. Comparing prospective and retrospective measures of treatment outcomes. Med Care. 1995 Apr; 33(4 Suppl):AS67-76.
    View in: PubMed
  232. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care. 1995 Apr; 33(4 Suppl):AS145-55.
    View in: PubMed
  233. Barry MJ. Natural history of untreated benign prostatic hyperplasia. In: Garraway M, ed. Epidemiology of Prostate Disease. 1995; 132-144.
  234. Barry MJ. Editorial: "Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia". Urology. 1995; 45:405.
  235. Barry MJ. Editorial: "Correlation of American Urological Association Symptom Index with obstructive and nonobstructive prostatism". J Urol. 1995; 153:679.
  236. Barry MJ. Commentary: "A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer". ACP Journal Club. 1995; 123((1)):19.
  237. Barry MJ. Natural history of clinically localized prostate cancer. Semin Surg Oncol. 1995 Jan-Feb; 11(1):3-8.
    View in: PubMed
  238. Barry MJ, Girman CJ, O'Leary MP, Walker-Corkery ES, Binkowitz BS, Cockett AT, Guess HA. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group. J Urol. 1995 Jan; 153(1):99-103.
    View in: PubMed
  239. Lu-Yao GL, Barry MJ, Chang CH, Wasson JH, Wennberg JE. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). Urology. 1994 Nov; 44(5):692-8; discussion 698-9.
    View in: PubMed
  240. Barry MJ. Proving early detection and treatment of prostate cancer does more good than harm: the need to support randomized trials actively. J Urol. 1994 Nov; 152(5 Pt 2):1903-4.
    View in: PubMed
  241. Wennberg JE, Barry MJ. Outcomes research. Science. 1994 May 6; 264(5160):758-9.
    View in: PubMed
  242. Monda JM, Barry MJ, Oesterling JE. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia. J Urol. 1994 May; 151(5):1291-5.
    View in: PubMed
  243. Emanuel LL, Barry MJ, Emanuel EJ, Stoeckle JD. Advance directives: can patients' stated treatment choices be used to infer unstated choices? Med Care. 1994 Feb; 32(2):95-105.
    View in: PubMed
  244. McConnell JD, Barry MJ, Bruskewitz RC. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin. 1994 Feb; (8):1-17.
    View in: PubMed
  245. Emanuel LL, Emanuel EJ, Stoeckle JD, Hummel LR, Barry MJ. Advance directives. Stability of patients' treatment choices. Arch Intern Med. 1994 Jan 24; 154(2):209-17.
    View in: PubMed
  246. Goodson JD, Barry MJ. Management of benign prostatic hyperplasia. In: Goroll AH, May LA, Mulley AG, eds. Primary Care Medicine. 1994; 705-8.
  247. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. In: Roberts RG, O'Leary MP, eds. Current Management of Benign Prostatic Hyperplasia. 1994; 3-10.
  248. Albertsen PC, Wasson JH, Barry MJ. Observation as a treatment option among men with clinically localized prostate cancer. In: Dawson N, Vogelzang NJ, eds. Prostate Cancer. 1994; 185-96.
  249. Barry MJ. Screening for colorectal cancer. In: Goroll AH, May L, Mulley AG, eds Primary Care Medicine. 1994; 311-5.
  250. Barry MJ. Editorial: "Benign prostatic hyperplasia: Effects on quality of life and impact on treatment decisions". Urology. 1994; 44:636.
  251. Sershon PD, Barry MJ, Oesterling JE. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. Eur Urol. 1994; 25(4):281-7.
    View in: PubMed
  252. Goodson JD, Barry MJ. Screening for prostate cancer. In: Goroll AH, May L, Mulley AG, eds. Primary Care Medicine. 1994; 657-9.
  253. Wennberg JE, Barry MJ, Fowler FJ, Mulley A. Outcomes research, PORTs, and health care reform. Ann N Y Acad Sci. 1993 Dec 31; 703:52-62.
    View in: PubMed
  254. Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology. 1993 Dec; 42(6):622-9.
    View in: PubMed
  255. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993 Aug; 150(2 Pt 1):351-8.
    View in: PubMed
  256. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993 May 26; 269(20):2650-8.
    View in: PubMed
  257. Barry MJ. Editorial: "A comparison of the AUA Symptom Index in unselected males and females between the ages of 55 and 79 years". Urology. 1993; 42:40.
  258. Fowler FJ, Barry MJ. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index. Eur Urol. 1993; 24 Suppl 1:24-7.
    View in: PubMed
  259. Barry MJ. Epidemiology and natural history of BPH. In: Lepor H, Lawson RK, eds. Prostate Diseases. 1993; 108-18.
  260. Barry MJ. Editorial: "American Urological Association Symptom Index for women with voiding symptoms: lack of index specificity for benign prostatic hyperplasia. J Urol. 1993; 150:1708-9.
  261. Barry MJ. Commentary: "Finasteride for benign prostatic hyperplasia". ACP Journal Club. 1993; 118(suppl 2):46.
  262. Barry MJ. Commentary: "Finasteride for benign prostatic hyperplasia". ACP Journal Club. 1993; 119(suppl 2):39.
  263. O'Leary MP, Barry MJ, Fowler FJ. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol. 1992 Nov; 148(5):1546-8; discussion 1564.
    View in: PubMed
  264. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol. 1992 Nov; 148(5):1558-63; discussion 1564.
    View in: PubMed
  265. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992 Nov; 148(5):1549-57; discussion 1564.
    View in: PubMed
  266. Cockett AT, Barry MJ, Holtgrewe HL, Sihelnick S, Williams R, McConnell J. Indications for treatment of benign prostatic hyperplasia. The American Urological Association Study. Cancer. 1992 Jul 1; 70(1 Suppl):280-3.
    View in: PubMed
  267. Bergner M, Barry MJ, Bowman MA, Doyle MA, Guess HA, Nutting PA. Where do we go from here? Opportunities for applying health status assessment measures in clinical settings. Med Care. 1992 May; 30(5 Suppl):MS219-30.
    View in: PubMed
  268. Barry MJ, et al. Shared Decision-making Program for Mild Hypertension (interactive videodisc). 1992.
  269. Emanuel LL, Barry MJ, Stoeckle JD, Ettelson LM, Emanuel EJ. Advance directives for medical care--a case for greater use. N Engl J Med. 1991 Mar 28; 324(13):889-95.
    View in: PubMed
  270. Barry MJ. Guidelines: physicians in the lead. Health Manage Q. 1991; 13(2):20-3.
    View in: PubMed
  271. Barry MJ. Testing for Human Immunodeficiency Virus infection. In: Griner P, Panzer R, Black E, eds. Diagnostic Strategies for Common Medical Problems. 1991; 430-6.
  272. Barry MJ. Screening for nonpalpable prostate cancer. In: Griner P, Panzer R, Black E, eds. Diagnostic Strategies for Common Medical Problems. 1991; 217-26.
  273. Barry MJ, et al. Shared Decision-making Program for Benign Prostatic Hyperplasia (interactive videodisc). 1991.
  274. Malenka DJ, Roos N, Fisher ES, McLerran D, Whaley FS, Barry MJ, Bruskewitz R, Wennberg JE. Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis. J Urol. 1990 Aug; 144(2 Pt 1):224-7; discussion 228.
    View in: PubMed
  275. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990 Aug; 17(3):495-507.
    View in: PubMed
  276. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate Suppl. 1990; 3:61-74.
    View in: PubMed
  277. Lyons HC, Henderson JV, Beck JR, Mulley AG, Barry MJ, Fowler FJ, Wennberg CN, Wennberg JE. A multipurpose interactive videodisc with ethical, legal, medical, educational and research implications: the informed patient decision-making procedure. 1989; (1989):1043-5.
  278. Richter JM, Goodson JD, Barry MJ, Treadway KK. Medical diagnostic technology in the home. Int J Technol Assess Health Care. 1989; 5(1):53-61.
    View in: PubMed
  279. Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D. Symptom status and quality of life following prostatectomy. JAMA. 1988 May 27; 259(20):3018-22.
    View in: PubMed
  280. Barry MJ, Mulley AG, Fowler FJ, Wennberg JW. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. JAMA. 1988 May 27; 259(20):3010-7.
    View in: PubMed
  281. Wennberg JE, Mulley AG, Hanley D, Timothy RP, Fowler FJ, Roos NP, Barry MJ, McPherson K, Greenberg ER, Soule D, et al. An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA. 1988 May 27; 259(20):3027-30.
    View in: PubMed
  282. Barry MJ, Mulley AG, Richter JM. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology. 1987 Aug; 93(2):301-10.
    View in: PubMed
  283. Barry MJ. Screening for colorectal cancer. In: Goroll AH, May LA, Mulley AG, eds. Primary Care Medicine. 1987; 252-5.
  284. Barry MJ. Screening for colorectal cancer. In: Primary Care Medicine. 1987; 252-5.
  285. Richter JM, Barry MJ. Decision analysis for the practicing gastroenterologist. 2. Insights into the efficacy of diagnostic strategies using decision analysis. Am J Gastroenterol. 1985 Jun; 80(6):493-7.
    View in: PubMed
  286. Barry MJ. Fecal occult blood testing for colorectal cancer. MGH Laboratory Newsletter. 1984; 16:4-6.
  287. Barry MJ. Therapeutic experience with patients referred for "prolonged grief reaction"--some second thoughts. Mayo Clin Proc. 1981 Dec; 56(12):744-8.
    View in: PubMed
  288. Barry MJ. The prolonged grief reaction. Mayo Clin Proc. 1973 May; 48(5):329-35.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Barry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_